American drug-maker ViiV Healthcare, which specialises in HIV, announced Monday (21 December) that the European Commission gas had rubber-stumped the revolutionary, long-acting regimen, Read More
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.